3'-fucosyllactose has been researched along with Infection in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Borkowski, J; Hüfner, E; Jennewein, S; Putze, J; Schroten, H; Weichert, S; Weiss, C | 1 |
1 other study(ies) available for 3'-fucosyllactose and Infection
Article | Year |
---|---|
Bioengineered 2'-fucosyllactose and 3-fucosyllactose inhibit the adhesion of Pseudomonas aeruginosa and enteric pathogens to human intestinal and respiratory cell lines.
Topics: Anti-Bacterial Agents; Bacterial Adhesion; Biocatalysis; Bioengineering; Breast Feeding; Caco-2 Cells; Campylobacter jejuni; Enteropathogenic Escherichia coli; Epithelial Cells; Gram-Negative Bacteria; Humans; Infections; Intestines; Milk, Human; Oligosaccharides; Pseudomonas aeruginosa; Respiratory System; Salmonella enterica; Trisaccharides | 2013 |